Brainsway has launched a new era in the treatment of depression, with Brainsway Deep TMS therapy, or Deep Magnetic Transcranial Stimulation. With this advanced depression treatment, patients can regain stability, calm and happiness in just a few weeks.
Brainsway Deep TMS therapy has been proven to be highly effective, safe and well-tolerated for treating patients with severe, persistent depression. It is FDA cleared for patients who tried several types of antidepressants without improving. Brainsway's TMS therapy is non-invasive, does not generate systemic side effects, and does not require hospitalization or anesthesia.
Brainsway Deep TMS therapy stimulates the brain regions responsible for depression in a non-invasive way, using brief magnetic fields, similar to those used in magnetic resonance imaging (MRI) systems.
Brainsway's Deep TMS therapy has been widely tested, participating in over 60 clinical trials worldwide. It is based on patents registered by the U.S. National Institutes of Health (NIH) and the company.